Results 81 to 90 of about 9,019 (158)

From concept to clinical practice: the evolution of low- and ultra-low-dose triple combination therapy for hypertension. [PDF]

Clin Hypertens
Park JS, Sung KC, Rhee MY.
europepmc   +1 more source

Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT. [PDF]

Hypertension
Ahn JC, Lee CW, Ahn JH, Lim KH, Sohn IS, Sung KC, Kim KH, Bae JH, Hong SP, Jang WY, Jo SH, Han SH, Kim JB, Lee CJ, Lee JH, Kim N, Cho EJ, Sung JH, Ahn HS, Kim SY, Shin J, Seo SM, Hong SJ, Kim W, Park CG.   +24 more
europepmc   +1 more source

Telmisartan protects male reproductive function by modulating biochemical, oxidative stress, apoptosis, and DNA integrity in cyclophosphamide-exposed rats. [PDF]

Toxicol Rep
Kassid AA, Mahmood AM, Obaid KA, Philip Rahmani MH.   +3 more
europepmc   +1 more source

Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors. [PDF]

Alzheimers Dement
Liu CH, Tsai ML, Yang NI, Chang TY, Chen TH, Wei YC.   +5 more
europepmc   +1 more source

Comparative effectiveness of telmisartan vs. other angiotensin receptor blockers in reducing hypertension-related cerebrovascular and cardiovascular events: a real-world retrospective study using the TriNetX network. [PDF]

Front Cardiovasc Med
Chen TY, Lin YC, Liu GY, Hung HC.
europepmc   +1 more source

Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Goh S, Huh KY, Lee S, Cho JY, Yu KS.
europepmc   +1 more source

Effect of Ang II Receptor Inhibition on GSK-3β/CREB/BDNF Signalling in REM Sleep Deprivation-Induced Memory Impairment. [PDF]

Neurochem Res
Elma N, Sayan Özaçmak H, Turan İ.
europepmc   +1 more source

Newly Synthesized Telmisartan-Amino Acid Conjugates Exhibit Enhanced Cytotoxic Effects in Malignant Melanoma Cells. [PDF]

Molecules
Vukadinović D, Damjanović A, Vuković M, Čudina O, Grahovac J, Dobričić V.   +5 more
europepmc   +1 more source

Telmisartan vs. other antihypertensives on cardiometabolic and vascular outcomes in diabetic hypertension: A randomised trial. [PDF]

Indian J Med Res
Gomaz SB, Kaur RJ, Mohandas A, Ambwani S, Charan J, Kumar D, Shukla R, Yadav D.   +7 more
europepmc   +1 more source

Assessing Renoprotective Effects of Empagliflozin and Telmisartan Combination Therapy in Non-albuminuric Diabetic Nephropathy: A Retrospective Cohort Study. [PDF]

Cureus
Acharya A, Kotakala CMK, Kodanda Ramu B, Padala T, Aditya Reddy P, Patnaik PK, Niharika Mede B.   +6 more
europepmc   +1 more source